• Research Tree
  • Features
  • Pricing
  • Events
  • Reg.News
  • Short Interest
  • Explore Content
    • Explore

      • Providers
        • Providers

          • Free/Commissioned
          • High Net Worth Offering
          • Institutional Offering

          Free/Commissioned

          Research that is free to access for all investors. Companies commission these providers to write research about them.

          View Research

          What is our Main Bundle Offering?

          Brokers who write research on their corporate clients and make it available through our main bundle offering.

          View Research

          What is Institutional?

          Research that is paid for directly by asset managers. Only accessible to institutional investors permissioned for access.

          View Research
      • Regions
        • Regions

          • UK
          • Rest of EMEA
          • N America
          • APAC
          • LatAm
      • Exchanges
        • Exchanges

          • Aquis Apex
          • Australian Securities Exchange
          • Canadian Securities Exchange
          • Euronext Paris
          • London Stock Exchange (domestic)
          • SIX Swiss Exchange
      • Sectors
        • Sector Coverage

          • Building & Construction
          • Discretionary Personal Goods
          • Discretionary Retail
          • Energy
          • Health
          • Investment Trusts
          • Media
          • Resources
          • Technology
      • Small / Large Cap
        • Small / Large Cap

          • UK100
          • UK250
          • UK Smallcap
          • UK Other Main Markets
          • Other
  • Login
  • Sign Up
LIVE

Event in Progress:

Join Here ×

working
  • 07 Jan 2026

Client Demand Trends Led By Strong Global M&A Activity Bode Well For CRAI, In Our View; Our Unchanged 2025-2027 EPS Estimates And Free Cash Flow Support Street High $260 Price Target


CRA INTERNATIONAL (CRAI:NYSE) | 0 0 0.0%


  • Sidoti & Company
    • Marc Riddick, CFA

    • 10 pages


 

CRAI's management participated in the Sidoti Year End Virtual Conference last month, reiterating the company's key drivers for client demand. Global merger and acquisition activity finished strong in 2025, with deal value up 34% year over year in 4Q:25, further supporting demand trends at year-end. Management boosted its 2025 guidance in November to revenue (on a constant currency basis) of $740-$748 million (versus our $743.0 million estimate). Our unchanged EPS estimates of $8.25 in 2025, $8.83 in 2026 and $9.92 in 2027 imply annual growth of 8.6%, 7.1% and 12.4%, respectively. Our free cash flow per share (excluding the add back of stock-based compensation expense) estimates of $11.41 in 2025, $11.82 in 2026 and $12.80 in 2027 imply respective FCF yields of 5.3%, 5.5% and 6.0%. Our Street-high $260 price target is based on 24x our 2027 EPS estimate of $9.92, plus projected year-end 2027 net cash per share of $21.82. On a P/E-only basis, our price target implies a 26.2x multiple of our 2027 EPS estimate, which we view as consistent with premium consulting peers. Positive fundamentals and free cash flow support our valuation and the moderate risk rating, in our view.

Sign up for free to access

Get access to the latest equity research in real-time from 12 commissioned providers.

Get access to the latest equity research in real-time from 12 commissioned providers.


Get Started
Already a member? Log in here
See all the research we have on this company.

Client Demand Trends Led By Strong Global M&A Activity Bode Well For CRAI, In Our View; Our Unchanged 2025-2027 EPS Estimates And Free Cash Flow Support Street High $260 Price Target


CRA INTERNATIONAL (CRAI:NYSE) | 0 0 0.0%


  • Published: 07 Jan 2026
  • Author: Marc Riddick, CFA
  • Pages: 10
  • Sidoti & Company


CRAI's management participated in the Sidoti Year End Virtual Conference last month, reiterating the company's key drivers for client demand. Global merger and acquisition activity finished strong in 2025, with deal value up 34% year over year in 4Q:25, further supporting demand trends at year-end. Management boosted its 2025 guidance in November to revenue (on a constant currency basis) of $740-$748 million (versus our $743.0 million estimate). Our unchanged EPS estimates of $8.25 in 2025, $8.83 in 2026 and $9.92 in 2027 imply annual growth of 8.6%, 7.1% and 12.4%, respectively. Our free cash flow per share (excluding the add back of stock-based compensation expense) estimates of $11.41 in 2025, $11.82 in 2026 and $12.80 in 2027 imply respective FCF yields of 5.3%, 5.5% and 6.0%. Our Street-high $260 price target is based on 24x our 2027 EPS estimate of $9.92, plus projected year-end 2027 net cash per share of $21.82. On a P/E-only basis, our price target implies a 26.2x multiple of our 2027 EPS estimate, which we view as consistent with premium consulting peers. Positive fundamentals and free cash flow support our valuation and the moderate risk rating, in our view.

More Content

More Content

Potential Fed Rate Cut Represents A Near-Term Catalyst For CRAI, In Our View; Strong Client Demand Trends Support Our 2025-2027 Estimates; Free Cash Flow Bolsters Our $260 Price Target

Companies: CRA INTERNATIONAL

Sidoti & Company

Our 2Q:25 EPS Estimate Of $2.00 (Up From $1.83 In The Prior Year Period) Supported By Demand Driven Revenue Gains; Strong Free Cash Flow Supports Our $247 Price Target, In Our View

Companies: CRA INTERNATIONAL

Sidoti & Company

Broad-Based Revenue Strength Drives 3Q:25 EPS Above Our Estimate; We Increase Our 2025 EPS Estimate And Introduce Our 2027 Forecast; Raise Price Target To $260 (From $253)

Companies: CRA INTERNATIONAL

Sidoti & Company

Our 3Q:25 EPS Estimate Of $1.82 Implies Modest Growth Against A Strong Year-Ago Comparison; Steady 2025-2026 EPS Growth, Free Cash Flow Gains Support $253 Price Target, In Our View

Companies: CRA INTERNATIONAL

Sidoti & Company

Takeaways From The Sidoti Conference: CRAI Remains Well Positioned For Anticipated Ongoing Economic Uncertainty And Potential M&A Growth, In Our View; Raise Target To $253 (From $244)

Companies: CRA INTERNATIONAL

Sidoti & Company
Research Tree
Useful Links
  • Features
  • Pricing
  • RNS/Newswires Feeds
  • Providers Hub
  • Company Hub
  • Stock Pick League
  • iOS and Android Apps
Account
  • Login
  • Join Now
  • Contact
  • Follow us on Linkedin
  • Follow us on X

© Research Tree 2026

  • Apple Store
  • Play Store
  • Terms of Service
  • Privacy Policy and Statement on Cookies

Research Tree will never share your details with third parties for marketing purposes. Research Tree distributes research documents that have been produced and approved by Financial Conduct Authority (FCA) Authorised & Regulated firms as well as relevant content from non-authorised sources, who are not regulated but the information is in the public domain. For the avoidance of doubt Research Tree is not giving advice, nor has Research Tree validated any of the information.

Research Tree is an Appointed Representative of Sturgeon Ventures which is Authorised and Regulated by the Financial Conduct Authority.

Top
  • Home
  • Features
  • Pricing
  • Event Hub
  • Reg.News
  • Short Interest Tracker
  • Explore Content
    • Regions
      • UK
      • Rest of EMEA
      • N America
      • APAC
      • LatAm
    • Exchanges
      • Aquis Apex
      • Australian Securities Exchange
      • Canadian Securities Exchange
      • Euronext Paris
      • London Stock Exchange (domestic)
      • SIX Swiss Exchange
    • Sectors
      • Automobile Industry
      • Banks
      • Building & Construction
      • Chemicals
      • Discretionary Personal Goods
      • Discretionary Retail
      • Energy
      • ETFs
      • Financial Services
      • Food & Drink
      • Food Production
      • Health
      • Household Goods & DIY
      • Industrial Equipment, Goods & Services
      • Insurance & Reinsurance
      • Investment Trusts
      • Leisure, Tourism & Travel
      • Media
      • Open-ended Funds
      • Other
      • Real Estate
      • Resources
      • Staple Retail
      • Technology
      • Telecoms
      • Trusts, ETFs & Funds
      • Utilities
    • Small / Large Cap
      • UK100
      • UK250
      • UK Smallcap
      • UK Other Main Markets
      • Other
    • Private/EIS
      • EIS Single Company
      • EIS/SEIS Funds
      • IHT Products
      • SEIS Single Company
      • VCT Funds
  • Providers
    • Free/Commissioned
      • Actinver
      • Actio Advisors
      • Allenby Capital
      • Asset TV
      • Astris Advisory
      • Atrium Research
      • Baden Hill
      • BlytheRay
      • BNP Paribas Exane - Sponsored Research
      • Bondcritic
      • Bowsprit Partners Limited
      • Brand Communications
      • Brokerlink
      • BRR Media
      • Calvine Partners
      • Capital Access Group
      • Capital Link
      • Capital Markets Brokers
      • Cavendish
      • Checkpoint Partners
      • Clear Capital Markets
      • Couloir Capital
      • Doceo
      • Edison
      • EM Spreads
      • Engage Investor
      • Equity Development
      • eResearch
      • First Equity
      • Five Minute Pitch TV
      • focusIR
      • Fundamental Research Corp
      • Galliano’s Latin Notes
      • GBC AG
      • goetzpartners securities Limited
      • Golden Section Capital
      • GreenSome Finance
      • GSBR Research
      • H2 Radnor
      • Hardman & Co
      • Holland Advisors
      • Hypothesis Research
      • InterAxS Global
      • Kepler | Trust Intelligence
      • London Stock Exchange
      • Longspur Clean Energy
      • Mello Events
      • Messari Research
      • Morphose Capital Partners
      • MUFG Corporate Markets IR
      • Nippon Investment Bespoke Research UK
      • NuWays
      • OAK Securities
      • Oberon Capital
      • Optimo Capital
      • Panmure Liberum
      • Paul Scott
      • Peel Hunt
      • PIWORLD / Progressive
      • Proactive
      • Progressive Equity Research
      • Quantum Research Group
      • QuotedData
      • RaaS Research Group
      • Research Dynamics
      • Research Tree
      • Resolve Research
      • SEAL Advisors Ltd
      • ShareSoc
      • Shore Capital
      • Sidoti & Company
      • Small Cap Consumer Research LLC
      • StockBox
      • Tennyson Securities
      • The AIC
      • The Business Magazine Group
      • The Curious Compounder
      • The Edge Group
      • The Life Sciences Division
      • ThinkFront
      • Tring Triangle
      • Trinity Delta
      • Turner Pope Investments
      • UK Investor Group
      • ValueTrack
      • Vox Markets
      • VRS International S.A. - Valuation & Research Specialists (VRS)
      • VSA Capital
      • Winterflood Securities
      • World Platinum Investment Council
      • Yaru Investments
      • Yellowstone Advisory
      • Zacks Small Cap Research
      • Zeus Capital
    • High Net Worth Offering
      • ABG Sundal Collier
      • ACF Equity Research
      • Acquisdata
      • AlphaValue
      • Alternative Resource Capital
      • Arctic Securities
      • Arden Partners
      • Auctus Advisors
      • Baptista Research
      • BNP Paribas Exane - Sponsored Research
      • Canaccord Genuity
      • Cavendish
      • Couloir Capital
      • Degroof Petercam
      • Dowgate Capital
      • First Berlin
      • First Equity
      • First Sentinel
      • Greenwood Capital Partners
      • Hannam & Partners
      • Hybridan
      • ISTAR Capital
      • Kemeny Capital
      • Longspur Clean Energy
      • Louis Capital
      • Magnitogorsk Iron and steel works
      • Medley Global Advisors
      • Northland Capital Partners
      • OAK Securities
      • Oberon Capital
      • Panmure Liberum
      • QuotedData Professional
      • Shard Capital
      • ShareSoc
      • Shore Capital
      • Singer Capital Markets
      • SP Angel
      • Stanford Capital Partners
      • Stifel FirstEnergy
      • Stockdale Securities
      • Tamesis Partners
      • Tennyson Securities
      • The Life Sciences Division
      • Turner Pope Investments
      • VSA Capital
      • Whitman Howard
      • xxxxxx_deleted
      • Yellowstone Advisory
      • Zeus Capital
    • Institutional Offering
      • ABG Sundal Collier
      • ACF Equity Research
      • Alternative Resource Capital
      • Arctic Securities
      • Arden Partners
      • Auctus Advisors
      • BNP Paribas Exane
      • Bondcritic
      • Canaccord Genuity
      • Capital Access Group
      • Capital Link
      • Cavendish
      • Couloir Capital
      • Degroof Petercam
      • Dowgate Capital
      • Edison
      • First Berlin
      • First Equity
      • First Sentinel
      • Five Minute Pitch TV
      • Fundamental Research Corp
      • Galliano’s Latin Notes
      • GBC AG
      • Golden Section Capital
      • Goodbody
      • Greenwood Capital Partners
      • Hannam & Partners
      • Holland Advisors
      • Hybridan
      • InterAxS Global
      • Investec Bank
      • ISTAR Capital
      • Kepler | Trust Intelligence
      • Longspur Clean Energy
      • Numis
      • NuWays
      • OAK Securities
      • Oberon Capital
      • Panmure Liberum
      • Peel Hunt
      • QuotedData
      • QuotedData Professional
      • Research Dynamics
      • Research Tree
      • Shard Capital
      • Shore Capital
      • Sidoti & Company
      • Singer Capital Markets
      • Small Cap Consumer Research LLC
      • SP Angel
      • Stanford Capital Partners
      • Stifel
      • StockBox
      • Tamesis Partners
      • Tennyson Securities
      • The AIC
      • The Business Magazine Group
      • The Life Sciences Division
      • Tring Triangle
      • ValueTrack
      • Velocity Trade
      • VSA Capital
      • Winterflood Securities
      • World Platinum Investment Council
      • Zacks Small Cap Research
      • Zeus Capital
  • Contact
  • Sign Up
  • Sign In